Detection of double target binders at the single cell level: an evaluation of the specificity of NK and MLC-induced NK-like cells |
| |
Authors: | P J D'Amore S H Golub |
| |
Institution: | 1. Department of Pathology, UCLA School of Medicine, Los Angeles, California 90024 USA;2. Department of Surgery/Division of Oncology, UCLA School of Medicine, Los Angeles, California 90024 USA |
| |
Abstract: | MLC-generated cells were tested on 7 consecutive days in the single cell cytotoxicity assay to determine the kinetics of natural and allospecific killing. Maximum cytotoxicity to the NK-sensitive target, K562, was found on Day 3 of MLC with an increase at that time in both the number of cells binding and the number of cells killing K562. The maximum allospecific response was found on Days 6 and 7 with an increase in cells able to bind and kill the alloantigen-bearing target. To determine whether the anti-K562 and allospecific killing were mediated by the same effector cells or different cell populations, both targets were tested simultaneously in the single cell assay. At no time during the 7 days were cells detected capable of simultaneously binding both K562 and allospecific targets. These data indicate that there are two different cell populations responsible for allospecific cytotoxicity and MLC-induced NK-like cytotoxicity. The cytotoxic specificity of unstimulated and MLC-generated NK-like cells was also investigated. When two different NK-sensitive targets (e.g., K562 and MOLT-4) were tested together in the single cell assay, there was no concurrent binding of targets by either fresh PBL prior to MLC stimulation or Day 3 MLC-generated cells. When unstimulated effector cells were enriched for NK activity by Percoll density gradient centrifugation, only a small number of effector cells simultaneously binding two different NK-sensitive targets was detected in the single cell assay. These results imply that the NK cell population is heterogeneous and composed of subpopulations recognizing diverse target specificities. |
| |
Keywords: | To whom correspondence should be addressed: UCLA School of Medicine Surgery/Oncology 54-140 Center for Health Sciences Los Angeles Calif 90024 |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|